FDA approves PureTech’s obesity device Plenity
Lancet research reveals scale of problem
Three years after launching a forward-thinking diabetes prevention programme, NHS England yesterday hailed early signs of a very significant impact on those at-risk people taking part.
Label will reflect heart benefit seen in LEADER trial.
Body cites uncertainty over manufacturer’s data.
Trends in diagnostic and patient monitoring devices, including wearables, mHealth apps and wireless technology.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.